221 related articles for article (PubMed ID: 19336760)
1. Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia.
Sulahian R; Cleaver O; Huang LJ
Blood; 2009 May; 113(21):5287-97. PubMed ID: 19336760
[TBL] [Abstract][Full Text] [Related]
2. Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis.
Bulut GB; Sulahian R; Yao H; Huang LJ
Blood; 2013 Dec; 122(24):3964-72. PubMed ID: 24113870
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
4. Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.
Huang LJ; Shen YM; Bulut GB
Br J Haematol; 2010 Mar; 148(6):844-52. PubMed ID: 20096014
[TBL] [Abstract][Full Text] [Related]
5. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.
Kralovics R; Indrak K; Stopka T; Berman BW; Prchal JF; Prchal JT
Blood; 1997 Sep; 90(5):2057-61. PubMed ID: 9292543
[TBL] [Abstract][Full Text] [Related]
6. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
7. Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles.
Singh S; Verma R; Pradeep A; Leu K; Mortensen RB; Young PR; Oyasu M; Schatz PJ; Green JM; Wojchowski DM
PLoS One; 2012; 7(1):e29064. PubMed ID: 22253704
[TBL] [Abstract][Full Text] [Related]
8. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor.
Divoky V; Song J; Horvathova M; Kralova B; Votavova H; Prchal JT; Yoon D
J Mol Med (Berl); 2016 May; 94(5):597-608. PubMed ID: 26706855
[TBL] [Abstract][Full Text] [Related]
9. Polycythaemia-inducing mutations in the erythropoietin receptor (EPOR): mechanism and function as elucidated by epidermal growth factor receptor-EPOR chimeras.
Gross M; Ben-Califa N; McMullin MF; Percy MJ; Bento C; Cario H; Minkov M; Neumann D
Br J Haematol; 2014 May; 165(4):519-28. PubMed ID: 24533580
[TBL] [Abstract][Full Text] [Related]
10. Genetic heterogeneity of primary familial and congenital polycythemia.
Kralovics R; Prchal JT
Am J Hematol; 2001 Oct; 68(2):115-21. PubMed ID: 11559951
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.
Miura O; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
Blood; 1994 Sep; 84(5):1501-7. PubMed ID: 8068943
[TBL] [Abstract][Full Text] [Related]
12. Increased cell surface expression of C-terminal truncated erythropoietin receptors in polycythemia.
Motohashi T; Nakamura Y; Osawa M; Hiroyama T; Iwama A; Shibuya A; Nakauchi H
Eur J Haematol; 2001 Aug; 67(2):88-93. PubMed ID: 11722595
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis.
Tauchi T; Damen JE; Toyama K; Feng GS; Broxmeyer HE; Krystal G
Blood; 1996 Jun; 87(11):4495-501. PubMed ID: 8639815
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor.
Miura O; Nakamura N; Ihle JN; Aoki N
J Biol Chem; 1994 Jan; 269(1):614-20. PubMed ID: 8276859
[TBL] [Abstract][Full Text] [Related]
15. Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia.
Kralovics R; Sokol L; Prchal JT
J Clin Invest; 1998 Jul; 102(1):124-9. PubMed ID: 9649565
[TBL] [Abstract][Full Text] [Related]
16. Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis.
Ueda F; Tago K; Tamura H; Funakoshi-Tago M
J Biol Chem; 2017 Feb; 292(5):1826-1846. PubMed ID: 27998978
[TBL] [Abstract][Full Text] [Related]
17. EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.
Perrotta S; Cucciolla V; Ferraro M; Ronzoni L; Tramontano A; Rossi F; Scudieri AC; Borriello A; Roberti D; Nobili B; Cappellini MD; Oliva A; Amendola G; Migliaccio AR; Mancuso P; Martin-Padura I; Bertolini F; Yoon D; Prchal JT; Della Ragione F
PLoS One; 2010 Aug; 5(8):e12015. PubMed ID: 20700488
[TBL] [Abstract][Full Text] [Related]
18. Familial polycythemia due to truncations of the erythropoietin receptor.
Forget BG; Degan BA; Arcasoy MO
Trans Am Clin Climatol Assoc; 2000; 111():38-44; discussion 44-5. PubMed ID: 10881330
[TBL] [Abstract][Full Text] [Related]
19. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor.
Miura O; Miura Y; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
Blood; 1994 Dec; 84(12):4135-41. PubMed ID: 7527668
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state.
Watowich SS; Xie X; Klingmuller U; Kere J; Lindlof M; Berglund S; de la Chapelle A
Blood; 1999 Oct; 94(7):2530-2. PubMed ID: 10498627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]